This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window

American Economic Review: Vol. 102 No. 6 (October 2012)
AER Volume. 102, Issue 6 |
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter
AER Forthcoming Articles
Full-text Article
Download Data Set (140.71 KB) | Online Appendix (209.68 KB)
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter
Explore:
AER Forthcoming Articles
Physician Agency and Adoption of Generic Pharmaceuticals
Article Citation
Iizuka, Toshiaki. 2012. "Physician Agency and Adoption of Generic Pharmaceuticals."
American Economic Review,
102(6): 2826-58.
DOI: 10.1257/aer.102.6.2826
DOI: 10.1257/aer.102.6.2826
Abstract
I examine physician agency in health care services in the context of the choice between brand-name and generic pharmaceuticals. I examine micro-panel data from Japan, where physicians can legally make profits by prescribing and dispensing drugs. The results indicate
that physicians often fail to internalize patient costs, explaining
why cheaper generics are infrequently adopted. Doctors respond to markup differentials between the two versions, indicating another agency problem. However, generics' markup advantages are shortlived, which limits their impact on increasing generic adoption.
Additionally, state dependence and heterogeneous doctor preferences
affected generics' adoption. Policy makers can target these factors to improve static efficiency. (JEL D82, I11, J44, L65)
Article Full-Text Access
Full-text Article
Additional Materials
Download Data Set (140.71 KB) | Online Appendix (209.68 KB)
Authors
Iizuka, Toshiaki (U Tokyo)
JEL Classifications
D82: Asymmetric and Private Information; Mechanism Design
I11: Analysis of Health Care Markets
J44: Professional Labor Markets; Occupational Licensing
L65: Chemicals; Rubber; Drugs; Biotechnology
I11: Analysis of Health Care Markets
J44: Professional Labor Markets; Occupational Licensing
L65: Chemicals; Rubber; Drugs; Biotechnology

